Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis System

A Prior Information Notice
by NHS BLOOD AND TRANSPLANT, BRISTOL

Source
Find a Tender
Type
Contract (Goods)
Duration
2 year
Value
£0-£100K
Sector
HEALTH
Published
22 Apr 2025
Delivery
01 Aug 2025 to 31 Jul 2027
Deadline
n/a

Related Terms

Location

United Kingdom:

Geochart for 1 buyers and 0 suppliers

Description

NHSBT would like to consult the market to establish the likely level of interest for the consumables and maintenance where Low Density Lipoprotein removal is performed on Fresenius Medical Care (UK) Ltd. ART Universal machines at the following sites: Bristol and Leeds. NHS Blood and Transplant (NHBST) is a Special Health Authority within the NHS and is responsible for the provision of blood components and a range of associated laboratory and patient therapeutic services to hospitals in England and Wales. Therapeutic Apheresis Services (TAS) provide lifesaving and life-enhancing therapies to adults and children from across a range of clinical specialties. Patients receive treatment either at their hospital bedside or where clinically appropriate as an outpatient in an NHS Blood and Transplant (NHSBT) unit. NHSBT provides regional access to apheresis services from 11 dedicated units across England and Wales.

CPV Codes

  • 33000000 - Medical equipments, pharmaceuticals and personal care products
  • 50420000 - Repair and maintenance services of medical and surgical equipment
  • 33140000 - Medical consumables
  • 33693000 - Other therapeutic products

Indicators

  • Renewals are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-0505dc
  • FTS 016325-2025

Domains